Cytek Biosciences, Inc. CTKB
Set alert
6.13 USD -0.17 -2.70%
At close
6.36 +0.23 +3.75%
Pre-market · Nov 2, 3:03 AM ET
6.05 Day range 6.28
3.31 52-week range 6.34
- YTD
- +21.39%
- 1 year
- +60.47%
- Open
- 6.26
- Prev close
- 6.30
- Mkt cap
- 796.80M
- Vol
- 1.87M
- Avg vol
- 1.21M
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.05
- High
- 6.28
- Forward P/E
- 107.67
- Beta
- 1.32
- Short ratio
- 4.50
- Inst. own
- 59.02%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 6.03
- 200-d avg
- 5.92
- 1y target
- 8.40
News
3 days ago globenewswire.com
Cytek Biosciences to Participate in Upcoming Investor Conferences
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the…
4 days ago zacks.com
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
Cytek Biosciences (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.